TH161470B - Bacteria belonging to the genus Lactobacillus - Google Patents
Bacteria belonging to the genus LactobacillusInfo
- Publication number
- TH161470B TH161470B TH1501006330A TH1501006330A TH161470B TH 161470 B TH161470 B TH 161470B TH 1501006330 A TH1501006330 A TH 1501006330A TH 1501006330 A TH1501006330 A TH 1501006330A TH 161470 B TH161470 B TH 161470B
- Authority
- TH
- Thailand
- Prior art keywords
- intestinal tract
- lactic acid
- acid bacteria
- bacteria belonging
- genus lactobacillus
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 4
- 229940039696 Lactobacillus Drugs 0.000 title 1
- 241000186660 Lactobacillus Species 0.000 title 1
- 230000000968 intestinal Effects 0.000 claims abstract 4
- 241000186684 Lactobacillus pentosus Species 0.000 claims abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 3
- 235000014655 lactic acid Nutrition 0.000 abstract 3
- 239000004310 lactic acid Substances 0.000 abstract 3
- 210000000813 small intestine Anatomy 0.000 abstract 2
- 206010009887 Colitis Diseases 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary Effects 0.000 abstract 1
- 230000004584 weight gain Effects 0.000 abstract 1
- 235000019786 weight gain Nutrition 0.000 abstract 1
Abstract
Lactobacillus pentosus สายพันธุ์ TUA4337L (เลขทะเบียน NITE BP-1479) ที่มี ลักษณะเฉพาะที่ว่าสายพันธุ์มีความสามารถการเพิ่มจำนวนในลำไส้เล็กและ/หรือสำไส้ใหญ่และที่ควร ใช้คือลำไส้เล็กหลังจากที่มีชีวิตรอดในทางเดินลำไส้ เนื่องจากแบคทีเรียกรดแลคติกของการประดิษฐ์ นี้มีที่มีความสามารถการเพิ่มจำนวนในทางเดินลำไส้เมื่อถูกกลืนกินในร่างกาย แบคทีเรียกรดแลคติก จึงอยู่รอดไปถึงทางเดินลำไส้และเพิ่มจำนวนซึ่งดังนั้นการดูดซึมไขมันจะถูกขัดขวางอย่างต่อเนื่อง และการเพิ่มขึ้นของน้ำหนักสามารถถูกขัดขวางได้อย่างมีประสิทธิภาพ ดังนั้นแบคทีเรียกรดแลคติกจึง สามารถนำมาใช้อย่างเหมาะสมสำหรับวัตถุประสงค์ของผลการควบคุมอาหาร: Lactobacillus pentosus, TUA4337L (NITE Registration Number BP-1479), has the characteristics that the strain is capable of multiplying in the small intestine and / or colitis and that it should. Used is the small intestine after surviving in the intestinal tract. Due to the invention of lactic acid bacteria This has the ability to multiply in the intestinal tract when it is swallowed in the body. Lactic acid bacteria Therefore survive to the intestinal tract and increase the number, so fat absorption is continuously hindered. And weight gain can be effectively hindered. Therefore, lactic acid bacteria It can be used appropriately for the purpose of dietary results:
Claims (1)
Publications (3)
| Publication Number | Publication Date |
|---|---|
| TH161470B true TH161470B (en) | 2017-04-07 |
| TH161470A TH161470A (en) | 2017-04-07 |
| TH1501006330A TH1501006330A (en) | 2017-04-07 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4257194A3 (en) | Use of microbial communities for human and animal health | |
| MY183171A (en) | Composition containing bacterium belonging to genus lactobacillus | |
| MX2017014787A (en) | Bacterial populations for promoting health. | |
| EA201391823A1 (en) | SPRAY-DRIED STRAINS / LACTOBACTERIA CELLS AND THEIR APPLICATION AGAINST HELICOBACTER PYLORI | |
| MX2017016283A (en) | Lactobacillus paracasei for the production of conjugated linoleic acid, nutritional and pharmaceutical preparations containing it and uses thereof. | |
| WO2016106343A8 (en) | Probiotic organisms for diagnosis, monitoring, and treatment of inflammatory bowel disease | |
| MX2018002543A (en) | Compositions comprising urolithin compounds. | |
| MX2022011742A (en) | Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile. | |
| IL257684A (en) | Lactobacillus fermentum bacteria reducing the concentration of acetaldehyde | |
| PT3137635T (en) | Rapid acting lactobacillus strains and their use to improve aerobic stability of silage | |
| WO2015121458A3 (en) | Use of compositions comprising bifidobacterium animalis ssp. lactis lmg p-28149 | |
| MX2018002546A (en) | Compositions comprising an urolithin compound. | |
| EA034531B9 (en) | Composition comprising pediococcus pentosaceus bacteria inducing the production of il-10 by thp-1 macrophages | |
| JP2018083761A5 (en) | ||
| CO2018005952A2 (en) | Method for the detoxification of gluten proteins from cereal grains and their uses in the medical field | |
| MY174136A (en) | Bacterium belonging to genus lactobacillus | |
| RS20150852A1 (en) | New probiotic starter culture for human and animal use | |
| TH161470B (en) | Bacteria belonging to the genus Lactobacillus | |
| EA202191106A1 (en) | PROBIOTIC SUPPLEMENT FOR METABOLIC HEALTH CONTAINING LACTOBACILLUS | |
| TH161470A (en) | Bacteria belonging to the genus Lactobacillus | |
| JP2016003187A5 (en) | ||
| WO2016072854A3 (en) | Pantothenamide analogues | |
| TH169514A (en) | Constituents containing bacteria belonging to the genus Lactobacillus. | |
| del Carmen et al. | Use of probiotics in the treatment of Crohn's disease | |
| MY193625A (en) | Probiotic composition for treatment or prevention of high blood cholesterol |